Culturally Sensitive Intervention to Improve Retention in HIV Care for Latino MSM
PODER
1 other identifier
interventional
118
1 country
1
Brief Summary
The goal of this proposal is to culturally adapt and tailor an existing, theory-based intervention, using state-of-the-art methods designed to maximize cultural sensitivity, feasibility and acceptability to HIV+ Latino MSM, and to test it in a small randomized controlled trial (n=60 intervention; n=60 control).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1 hiv
Started Dec 2012
Typical duration for phase_1 hiv
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 19, 2011
CompletedFirst Posted
Study publicly available on registry
October 21, 2011
CompletedStudy Start
First participant enrolled
December 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2014
CompletedMay 27, 2015
May 1, 2015
1.5 years
October 19, 2011
May 26, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Retention in care
Retention in care will be assessed through the following measures: HIV medical care visits, ART use, self-reported adherence, acute care utilization, viral load, and health-related quality of life
Six month follow up
Secondary Outcomes (1)
Intermediate outcome variables
Six month follow up
Study Arms (2)
Intervention
EXPERIMENTALThis group will receive the peer navigator intervention.
Control
NO INTERVENTIONThis group will receive usual care.
Interventions
Peer navigators will teach HIV retention and linkage skills and knowledge using group-based as well as one-on-one, peer-based learning approaches.
Eligibility Criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AltaMed
Los Angeles, California, 90023, United States
Study Officials
- PRINCIPAL INVESTIGATOR
William E Cunningham, MD, MPH
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prinicipal Investigator
Study Record Dates
First Submitted
October 19, 2011
First Posted
October 21, 2011
Study Start
December 1, 2012
Primary Completion
June 1, 2014
Study Completion
September 1, 2014
Last Updated
May 27, 2015
Record last verified: 2015-05